Effects of dexmedetomidine on pain threshold, memory ability, and neurological function in sleep-deprived rats through expression of PSD95 protein and the phosphorylation level of the PI3K/AKT pathway
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: The study aimed to observe the effects of different doses of dexmedetomidine (Dex) on pain threshold, memory, and neurological ability in rats with sleep deprivation. MATERIAL AND METHODS: Forty-eight SD rats were divided into a control group (n = 12), model group (n = 12), sleep deprivation + Dex low dose injection group (DEX low dose group), and sleep deprivation + Dex high dose injection group (high dose DEX group). The rats in the model group, DEX low dose group, and DEX high dose group were subjected to sleep deprivation for 3 hours, and the DEX low dose group and DEX high dose group were injected with Dex (6 µg/kg, 60 µg/kg, 10 min, respectively). The neurological function scores of rats in each group were compared, and the contents of PSD95 and PI3K/AKT protein were detected. RESULTS: The food intake of rats in groups B, C, and D was lower than in group A (p < 0.05), and the food intake in group D was higher than in groups B and C (p < 0.05). The escape latency of the Morris water maze test in all groups decreased gradually from day 1 to day 3 (p < 0.05). On days 2 and 3, the escape latency of group B was longer than that of group A (p < 0.05), while the escape latency of groups C and D was shorter than that of group B (p < 0.05). The target quadrant residence time of group B was shorter than that of group A (p < 0.05), while the target quadrant residence time of group C and D was longer than that of group B (p < 0.05). The neurological function score of the group B was increased (p < 0.05), while the neurological function score of groups C and D was lower than that of group B in a dose-dependent manner (p < 0.05). The PSD95 protein content and PI3K/AKT phosphorylation level in group B were lower (p < 0.05), while these values in groups C and D were higher than in group B in a dose-dependent manner (p < 0.05). CONCLUSIONS: Different doses of Dex can effectively reduce the pain threshold, enhance memory ability, and improve neurological function in sleep-deprived rats. The mechanism may be mediated by regulation of PSD95 expression and phosphorylation of the PI3K/AKT pathway.
Fields of Study & Subjects
Sleep and Wakefulness Research
Anesthesia and Sedative Agents
Pain Mechanisms and Treatments
Publication details
- Journal / source
- Folia Neuropathologica
- Volume
- 64
- Issue
- 1
- Pages
- 105–112
- Publication date
- 1 January 2026
- Language
- EN